Novo Nordisk (NVO) said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to 2030 as production increases to meet demand for its obesity blockbuster ...

Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...

WEX Inc (NYSE:WEX) is set to release its Q4 2024 earnings on Feb 6, 2025. The consensus estimate for Q4 2024 revenue is ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.